USA Stock Peptidomimetic Substance Ftpp 2mg CAS 62568-57-4 Adipotide Peptide

• Customization: Available
• CAS No.: Adipotide
• Formula: Adipotide
• Model NO.: top quality
• EINECS: Adipotide
• Type: Pharmaceutical Intermediates
• Appearance: Powder
• Quality: Refined
• Colour: White
• Mf: C62h98n16o22
• Molecular Weight: 1419.53552
• Grade Standard: Medicine Grade
• MOQ: 1 Box
• COA: Pls Contact Senwayer Freely
• Storge: 2-8 Degree
• Exp.: 24 Months
• Transport Package: 10 Vials Per Box
• Specification: 2mg, 5mg or 10mg per vial, 10 vials per box
• Trademark: senwayer
• Origin: China
• HS Code: 2601111000
• Production Capacity: 4000 Boxes Per Month

Product Description

peptide powder Adipotide 2mg for Weight Loss peptides FTTP

Product description

Product name	Adipotide
CAS No.	N/A
Molecular Formula	C62H98N16O22
Molecular weight	1419.53552
Grade Standard	Medicine Grade
COA	Avaliable
Specification	2mg/vial

 

Physical Characters and specifications

Item	Specifications
Appearance	White powder.
Purity	99%min
Boiling point	1802.9±65.0ºC at 760 mmHg
Density	1.4±0.1 g/cm3
Refractive index	1.576
Flash point	1044.2±34.3ºC
Storage condition	2-8ºC
Shelf life	2 years

Adipotide is a new drug that is showing some promise in the area of obesity research. This drug was initially created as a cancer treatment designed to starve cancer cells of a blood supply so they would stop growing. The effects of Adipotide have shown that the drug actually starves fat cells of blood forcing them to die and be reabsorbed into the body. Initial tests were done on rats and then moved on to monkeys. The results from testing on rats showed a 30 percent decrease in body weight. After four weeks of daily injections of Adipotide followed by four weeks of non-treatment, 10 obese female rhesus monkeys lost an average of 11 percent of their body weight and 39 percent of fat deposits. Most of the loss was experienced during the non-treatment period.
 

Function

Adipotide, a peptidomimetic with sequence CKGGRAKDC-GG-D(KLAKLAK)2, is an experimental proapoptotic drug that has been shown to cause rapid weight loss in mice and rhesus monkeys. Its mechanism of action is to target specific blood vessels supplying adipose tissue with blood, cause the vessels to shrink and the fat cells fed by those vessels to undergo apoptosis.Adipotide is designed to bind to two receptors, ANXA2 and prohibitin, that are specific to blood vessels supplying white adipose tissue.